Learn about REAC technology, a new, non-invasive treatment for fibromyalgia. A recent study shows promising results in improving motor function and quality of life for patients

Fibromyalgia is a complex condition that causes widespread musculoskeletal pain, fatigue, sleep disturbances, and other symptoms that can significantly impact a person’s quality of life. Finding an effective treatment is often challenging.
A recent study, published in the Journal of Personalized Medicine, investigated a new technology called REAC (Radio Electric Asymmetric Conveyer) as a treatment for fibromyalgia.
Our body has its own “endogenous bioelectrical activity,” which is like an internal electrical communication network. In fibromyalgia, it is believed that this communication network isn’t functioning correctly. REAC technology is designed to interact with this bioelectrical activity and help it reorganize, aiming to restore normal cellular communication and neurological function.
The study involved 37 patients diagnosed with fibromyalgia who underwent two types of REAC treatment protocols:
To measure the effectiveness of the treatments, various tests were conducted before and after, including motor function tests and the Fibromyalgia Impact Questionnaire (FIQ).
The study’s results were very positive:
The findings suggest that REAC neuromodulation treatments could be an effective and safe therapeutic strategy for people with fibromyalgia. As a non-invasive and imperceptible treatment, it offers an alternative or addition to medication, with the potential to reduce the use of painkillers and improve the ability to perform daily activities.